Results 1 to 10 of about 7,517 (258)

Successful prevention of BK-polyomavirus nephropathy using extracorporeal photopheresis for immunosuppression minimisation following severe BK polyomavirus replication after kidney transplantation in a double lung transplant recipient, a case report [PDF]

open access: yesBMC Nephrology
Background BK-polyomavirus (BKpyV) nephropathy (BKVN) is associated with end-stage kidney disease in kidney and non-kidney solid organ transplantation, with no curative treatment.
Florent Von Tokarski   +12 more
doaj   +3 more sources

Extracorporeal Photopheresis Reduces Fibrotic and Inflammatory Transcriptomic Biological Marker of Chronic Antibody-mediated Kidney Rejection [PDF]

open access: yesTransplantation Direct
Background. The benefit of extracorporeal photopheresis on the course of kidney transplant rejection is unknown. The aim of our study was to investigate the variations in transcriptomics on graft biopsies when extracorporeal photopheresis was used to ...
Arnaud Lionet, MD   +9 more
doaj   +3 more sources

The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review [PDF]

open access: yesImmunoTargets and Therapy
Ayenew Berhan, Shewaneh Damtie, Andargachew Almaw, Biruk Legesse, Bekele Sharew, Birhanu Getie, Mulat Erkihun, Yenealem Solomon Department of Medical Laboratory Science, College of Health Science, Debre Tabor University, Debre Tabor ...
Berhan A   +7 more
doaj   +3 more sources

Extracorporeal photopheresis in stiff person syndrome [PDF]

open access: yesFrontiers in Immunology
Yandy Marx Castillo-Aleman   +1 more
doaj   +3 more sources

Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis [PDF]

open access: yesCase Reports in Dermatological Medicine, 2017
Nephrogenic systemic fibrosis (NSF), previously known as nephrogenic fibrosing dermopathy, is a rare complication of exposure to gadolinium-based contrast agents in patients who have significantly decreased renal function. Manifestations include fibrosis
Ranran Zhang, William Nicholas Rose
doaj   +2 more sources

Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial. [PDF]

open access: yesEur Respir J
Background Lung transplant recipients have the worst long-term outcomes of all solid organs due to acute rejection and chronic lung allograft dysfunction (CLAD).
Benazzo A   +15 more
europepmc   +2 more sources

Potential Mechanisms of Photopheresis in Hematopoietic Stem Cell Transplantation [PDF]

open access: hybrid, 2006
Immune tolerance describes specific unresponsiveness to antigens. In clinical situations such as graft-versus-host disease it may be useful to capitalize on these pre-existing tolerance mechanisms to treat patients.
Peritt, David
core   +3 more sources

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study [PDF]

open access: yesPractical Laboratory Medicine, 2023
Extracorporeal photopheresis is an established procedure for refractory graft-versus-host disease, a major complication associated with notable morbidity and mortality in patients with allogeneic hematopoietic stem cell transplant.
Adriana Sassone   +4 more
doaj   +2 more sources

The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need. [PDF]

open access: yesFront Immunol
Allograft rejection is a critical issue following solid organ transplantation (SOT). Immunosuppressive therapies are crucial in reducing risk of rejection yet are accompanied by several significant side effects, including infection, malignancy ...
Augusto JF   +3 more
europepmc   +2 more sources

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease. [PDF]

open access: yesJ Health Econ Outcomes Res
Background: The mainstay first-line therapy for chronic graft-vs-host disease (cGVHD) is corticosteroids; however, for steroid-refractory patients, there is a distinct lack of cost-effective or efficacious treatment.
Peacock A   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy